UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

The New England journal of medicine, 2020-12, Vol.383 (23), p.2219-2229

2020

Volltextzugriff (PDF)

Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors

Nature reviews cardiology, 2018-12, Vol.15 (12), p.731-743

2018

Volltextzugriff (PDF)

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality

The New England journal of medicine, 2018-04, Vol.378 (16), p.1509-1520

2018

Volltextzugriff (PDF)

Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients

The Lancet (British edition), 2023-06, Vol.401 (10393), p.2041-2050

2023

Volltextzugriff (PDF)

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

American journal of nephrology, 2019-11, Vol.50 (5), p.333-344

2019

Volltextzugriff (PDF)

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure

European heart journal, 2016-09, Vol.37 (33), p.2577-2585

2016

Volltextzugriff (PDF)

Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

Journal of hypertension, 2023-02, Vol.41 (2), p.295-302

2023

Volltextzugriff (PDF)

Preventing and managing hypertension: do not forget the night

Hypertension research, 2021-12, Vol.44 (12), p.1674-1675

2021

Volltextzugriff (PDF)

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

Frontiers in physiology, 2021-03, Vol.12, p.632260-632260

2021

Volltextzugriff (PDF)

Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease

American journal of nephrology, 2020-04, Vol.51 (4), p.294-303

2020

Volltextzugriff (PDF)

Serum Potassium and Clinical Outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)

Circulation (New York, N.Y.), 2008-10, Vol.118 (16), p.1643-1650

2008

Volltextzugriff (PDF)

Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'

Journal of hypertension, 2024-06, Vol.42 (6), p.961

Ruilope, Luis M

2024

Volltextzugriff (PDF)

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.2989-2998

2023

Volltextzugriff (PDF)

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

The New England journal of medicine, 2021-12, Vol.385 (24), p.2252-2263

2021

Volltextzugriff (PDF)

Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients

Journal of hypertension, 2017-12, Vol.35 (12), p.2388-2394

2017

Volltextzugriff (PDF)

Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications

American journal of nephrology, 2006-01, Vol.26 (3), p.232-244

2006

Volltextzugriff (PDF)

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European heart journal, 2022-02, Vol.43 (6), p.474-484

2022

Volltextzugriff (PDF)

White-coat UnControlled Hypertension, Masked UnControlled Hypertension, and True UnControlled Hypertension, phonetic and mnemonic terms for treated hypertension phenotypes

Journal of hypertension, 2018-02, Vol.36 (2), p.446-447

2018

Volltextzugriff (PDF)

The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease

International journal of molecular sciences, 2024-06, Vol.25 (13), p.7005

2024

Volltextzugriff (PDF)

Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study

Pharmaceuticals (Basel, Switzerland), 2024-09, Vol.17 (10), p.1299

2024

Volltextzugriff (PDF)

Differences Between Office and 24-Hour Blood Pressure Control in Hypertensive Patients With CKD: A 5,693-Patient Cross-sectional Analysis From Spain

American journal of kidney diseases, 2013-08, Vol.62 (2), p.285-294

2013

Volltextzugriff (PDF)

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

BMJ open, 2024-03, Vol.14 (3), p.e076444-e076444

2024

Volltextzugriff (PDF)

Physical Exercise in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Frontiers in cardiovascular medicine, 2022-05, Vol.9, p.893811-893811

2022

Volltextzugriff (PDF)

Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1322

2023

Volltextzugriff (PDF)

Sacubitril/valsartan in the treatment of arterial hypertension: an unaccomplished promise?

Hypertension research, 2017-05, Vol.40 (5), p.439-440

2017

Volltextzugriff (PDF)

1 – 25 von 714

Suche als RSS-Feed

Aktive Filter

ThemaAntihypertensive Agents - Therapeutic Use

ThemaBlood Pressure - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(671)
Mit Volltextzugriff
(630)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(359)
Life Sciences & Biomedicine
(357)
Humans
(279)
Cardiovascular System & Cardiology
(223)
Peripheral Vascular Disease
(152)
Hypertension
(122)
Male
(118)
Female
(107)
Biological And Medical Sciences
(106)
Medical Sciences
(105)
Risk Factors
(97)
Middle Aged
(82)
Cardiac & Cardiovascular Systems
(81)
Blood Pressure
(78)
Aged
(65)
Urology & Nephrology
(64)
Cardiology. Vascular System
(61)
Diabetes
(58)
Hypertension - Physiopathology
(58)
Blood And Lymphatic Vessels
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors

Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality

Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure

Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

Preventing and managing hypertension: do not forget the night

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease

Serum Potassium and Clinical Outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)

Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

Prevalence and clinical characteristics of white-coat hypertension based on different definition criteria in untreated and treated patients

Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

White-coat UnControlled Hypertension, Masked UnControlled Hypertension, and True UnControlled Hypertension, phonetic and mnemonic terms for treated hypertension phenotypes

The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease

Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study

Differences Between Office and 24-Hour Blood Pressure Control in Hypertensive Patients With CKD: A 5,693-Patient Cross-sectional Analysis From Spain

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

Physical Exercise in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Partial Genetic Deletion of Klotho Aggravates Cardiac Calcium Mishandling in Acute Kidney Injury

Sacubitril/valsartan in the treatment of arterial hypertension: an unaccomplished promise?

Aktive Filter

Suchergebnisse filtern